Celera Identifies FCAR Genetic Polymorphism Associated with Increased Risk for Myocardial Infarction
The Celera Genomics Group , an Applera Corporation business, today announced a publication describing a genetic polymorphism in the gene encoding the myeloid IgA Fc receptor, the FCAR Asp92Asn polymorphism, associated with